ES2045400T3 - Forma de dosificacion para suministrar un farmaco para la terapia humana. - Google Patents
Forma de dosificacion para suministrar un farmaco para la terapia humana.Info
- Publication number
- ES2045400T3 ES2045400T3 ES89300048T ES89300048T ES2045400T3 ES 2045400 T3 ES2045400 T3 ES 2045400T3 ES 89300048 T ES89300048 T ES 89300048T ES 89300048 T ES89300048 T ES 89300048T ES 2045400 T3 ES2045400 T3 ES 2045400T3
- Authority
- ES
- Spain
- Prior art keywords
- drug
- supply
- dosage form
- human therapy
- delivering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
LA INVENCION SE REFIERE A UN SISTEMA DE DOSIFICACION OSMOTICA PARA LIBERACION DEL FARMACO TERAPEUTICAMENTE BENEFICIOSO DOXAZOSIN EN EL MEDIO DE UTILIZACION, A LO LARGO DEL TIEMPO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/173,524 US4837111A (en) | 1988-03-21 | 1988-03-21 | Dosage form for dispensing drug for human therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2045400T3 true ES2045400T3 (es) | 1994-01-16 |
Family
ID=22632422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89300048T Expired - Lifetime ES2045400T3 (es) | 1988-03-21 | 1989-01-05 | Forma de dosificacion para suministrar un farmaco para la terapia humana. |
Country Status (12)
Country | Link |
---|---|
US (1) | US4837111A (es) |
EP (1) | EP0334465B1 (es) |
JP (1) | JP2729072B2 (es) |
AT (1) | ATE96308T1 (es) |
CA (1) | CA1315687C (es) |
DE (1) | DE68910159T2 (es) |
DK (1) | DK175637B1 (es) |
ES (1) | ES2045400T3 (es) |
HK (1) | HK1003980A1 (es) |
IE (1) | IE62131B1 (es) |
MX (1) | MX9203554A (es) |
PT (1) | PT90049B (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5023076A (en) * | 1987-02-27 | 1991-06-11 | Alza Corporation | Lamina comprising carboxyvinyl polymer |
IL91398A (en) * | 1988-08-30 | 1994-05-30 | Pfizer | A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane |
US5612059A (en) * | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
US5002540A (en) * | 1989-05-22 | 1991-03-26 | Warren Kirschbaum | Intravaginal device and method for delivering a medicament |
US5024843A (en) * | 1989-09-05 | 1991-06-18 | Alza Corporation | Oral hypoglycemic glipizide granulation |
US5120548A (en) * | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
WO1992002212A2 (en) * | 1990-08-07 | 1992-02-20 | Pfizer Inc. | Use of interfacially-polymerized membranes in delivery devices |
GB9101502D0 (en) * | 1991-01-23 | 1991-03-06 | Controlled Therapeutics Sct | Controlled release compositions |
US5208037A (en) * | 1991-04-22 | 1993-05-04 | Alza Corporation | Dosage forms comprising polymers comprising different molecular weights |
US5226902A (en) * | 1991-07-30 | 1993-07-13 | University Of Utah | Pulsatile drug delivery device using stimuli sensitive hydrogel |
US5200195A (en) * | 1991-12-06 | 1993-04-06 | Alza Corporation | Process for improving dosage form delivery kinetics |
US5254349A (en) * | 1991-12-06 | 1993-10-19 | Alza Corporation | Process for lessening irritation caused by drug |
US5266332A (en) * | 1991-12-06 | 1993-11-30 | Alza Corporation | Method for administering anti-Parkinson drug |
US5531734A (en) * | 1995-01-13 | 1996-07-02 | Abbott Laboratories | Method of altering composition of nutritional product during enteral tube feeding |
US5945125A (en) * | 1995-02-28 | 1999-08-31 | Temple University | Controlled release tablet |
US5713852A (en) * | 1995-06-07 | 1998-02-03 | Alza Corporation | Oral dosage and method for treating painful conditions of the oral cavity |
GB9523752D0 (en) * | 1995-11-21 | 1996-01-24 | Pfizer Ltd | Pharmaceutical formulations |
US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
EP0849265A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von Doxazosin-Mesylat (Form II) |
US6080132A (en) * | 1998-02-27 | 2000-06-27 | Abbott Laboratories | Apparatus for altering characteristics of a fluid |
US6309373B1 (en) | 1998-08-12 | 2001-10-30 | Abbott Laboratories | Apparatus for altering the characteristics of a fluid |
US6264695B1 (en) * | 1999-09-30 | 2001-07-24 | Replication Medical, Inc. | Spinal nucleus implant |
ATE318846T1 (de) * | 1999-11-12 | 2006-03-15 | Macromed Inc | An- und abschwellende polymermischungen |
US6537584B1 (en) | 1999-11-12 | 2003-03-25 | Macromed, Inc. | Polymer blends that swell in an acidic environment and deswell in a basic environment |
CA2395231C (en) | 1999-12-23 | 2006-08-15 | Pfizer Products Inc. | Hydrogel-driven layered drug dosage form |
US6464688B1 (en) | 2000-02-15 | 2002-10-15 | Microsolutions, Inc. | Osmotic pump delivery system with flexible drug compartment |
US6632217B2 (en) | 2001-04-19 | 2003-10-14 | Microsolutions, Inc. | Implantable osmotic pump |
ES2323264T3 (es) * | 2001-08-01 | 2009-07-10 | Novartis Ag | Composicion para enmascaramiento del sabor. |
KR100453288B1 (ko) * | 2002-03-12 | 2004-10-21 | 한국화학연구원 | 약물의 제어 방출을 위한 스퀴즈-유형의 삼투성 약물 전달장치 |
WO2006030402A2 (en) * | 2004-09-17 | 2006-03-23 | Ranbaxy Laboratories Limited | Dual compartment osmotic delivery device |
WO2006054152A1 (en) * | 2004-11-22 | 2006-05-26 | Ranbaxy Laboratories Limited | Monocompartment osmotic-controlled delivery system of doxazosin |
US20080039473A1 (en) * | 2006-08-08 | 2008-02-14 | Auspex Pharmaceuticals, Inc. | Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects |
CN101439026B (zh) * | 2007-11-23 | 2011-04-06 | 北京红林制药有限公司 | 含有多沙唑嗪或其盐的控释制剂及其制备方法 |
CN109589491B (zh) * | 2019-01-29 | 2024-01-09 | 上海安翰医疗技术有限公司 | 自动给药装置 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
US4188390A (en) * | 1977-11-05 | 1980-02-12 | Pfizer Inc. | Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines |
US4235236A (en) * | 1979-02-12 | 1980-11-25 | Alza Corporation | Device for dispensing drug by combined diffusional and osmotic operations |
US4320759A (en) * | 1980-04-28 | 1982-03-23 | Alza Corporation | Dispenser with diffuser |
US4309996A (en) * | 1980-04-28 | 1982-01-12 | Alza Corporation | System with microporous releasing diffusor |
US4532135A (en) * | 1981-02-09 | 1985-07-30 | Edwards K David G | Renoprotective treatments employing vasodilator compounds |
NZ206600A (en) * | 1983-05-11 | 1987-01-23 | Alza Corp | Osmotic drug delivery device |
US4765989A (en) * | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
US4760057A (en) * | 1983-06-23 | 1988-07-26 | Merck & Co., Inc. | (Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs |
US4609374A (en) * | 1985-04-22 | 1986-09-02 | Alza Corporation | Osmotic device comprising means for governing initial time of agent release therefrom |
US4842867A (en) * | 1986-05-09 | 1989-06-27 | Alza Corporation | Pulsed drug delivery of doxylamine |
EP0253554A3 (en) * | 1986-07-15 | 1988-07-20 | Pfizer Inc. | Controlled release drug-containing fibers |
US4758569A (en) * | 1987-08-26 | 1988-07-19 | Pfizer Inc. | Doxazosin as an anti-atherosclerosis agent |
-
1988
- 1988-03-21 US US07/173,524 patent/US4837111A/en not_active Expired - Lifetime
-
1989
- 1989-01-05 ES ES89300048T patent/ES2045400T3/es not_active Expired - Lifetime
- 1989-01-05 DE DE89300048T patent/DE68910159T2/de not_active Expired - Lifetime
- 1989-01-05 AT AT89300048T patent/ATE96308T1/de not_active IP Right Cessation
- 1989-01-05 EP EP89300048A patent/EP0334465B1/en not_active Expired - Lifetime
- 1989-01-18 IE IE14289A patent/IE62131B1/en not_active IP Right Cessation
- 1989-01-24 JP JP1014956A patent/JP2729072B2/ja not_active Expired - Lifetime
- 1989-01-26 CA CA000589192A patent/CA1315687C/en not_active Expired - Lifetime
- 1989-03-20 DK DK198901353A patent/DK175637B1/da not_active IP Right Cessation
- 1989-03-20 PT PT90049A patent/PT90049B/pt not_active IP Right Cessation
-
1992
- 1992-06-26 MX MX9203554A patent/MX9203554A/es unknown
-
1998
- 1998-04-16 HK HK98103203A patent/HK1003980A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE96308T1 (de) | 1993-11-15 |
EP0334465A1 (en) | 1989-09-27 |
IE890142L (en) | 1989-09-21 |
DK135389A (da) | 1989-09-22 |
DK175637B1 (da) | 2005-01-03 |
JP2729072B2 (ja) | 1998-03-18 |
EP0334465B1 (en) | 1993-10-27 |
HK1003980A1 (en) | 1998-11-13 |
IE62131B1 (en) | 1994-12-14 |
DE68910159T2 (de) | 1994-02-17 |
DE68910159D1 (de) | 1993-12-02 |
DK135389D0 (da) | 1989-03-20 |
CA1315687C (en) | 1993-04-06 |
MX9203554A (es) | 1992-09-01 |
PT90049B (pt) | 1995-03-01 |
JPH01242528A (ja) | 1989-09-27 |
PT90049A (pt) | 1989-11-10 |
US4837111A (en) | 1989-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2045400T3 (es) | Forma de dosificacion para suministrar un farmaco para la terapia humana. | |
IT8567263A0 (it) | Dispositivo di erogazione per la somministrazione controllata di un agente benefico particolamente di un farmaco a ruminanti | |
IT8667657A0 (it) | Nante dispositivo erogatore per la sommi nistrazione di un agente benefico all ambiente d uso particolarmente per la somministrazione di un agente terapeutico ad un animale rumi | |
MX148603A (es) | Mejoras en regulador de circulacion de un inyector de medicamentos en el cuerpo de animales | |
AR218037A1 (es) | Procedimiento para preparar un sistema terapeutico en la forma de un parche cutaneo para la administracion de la droga clonidina | |
FI935844A (fi) | En doseringsform foer foerdroejd befriande av ett laekemedel | |
ES2060941T3 (es) | Uso de nicotina para la fabricacion de un estuche para el tratamiento de condiciones susceptibles de dicho tratamiento. | |
DE69121885D1 (de) | Durch körperliche aktivität gesteuerte vorrichtung zur iontophoretischen verabreichung von medikamenten | |
ES513357A0 (es) | "un sistema terapeutico bajo la forma de un vendaje para administrar el medicamento". | |
HK1042485A1 (en) | Drugs that enhance synaptic responses mediated by ampa receptors | |
ATE69376T1 (de) | Haarwuchsmittel. | |
DE3769707D1 (de) | Therapeutisches system mit geregelter wirkstoffabgabe. | |
IT1221826B (it) | Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi | |
JPS5495575A (en) | Hydantoin derivative therapeutic medicine | |
ATE59550T1 (de) | Chlorpheniramine therapie. | |
KR900009029A (ko) | 가축병 치료용 약물을 투여하는 장치 | |
ES2081279T3 (es) | Utilizacion de 15-desoxiespergualina como medicamento. | |
GB1547562A (en) | Guns eg for use in the administration of drugs or medicines to animals | |
DE3689254D1 (de) | Arzneimittel auf Dextrorphanbasis zur intranasalen Applikation. | |
FR2494658B1 (fr) | Corps de patins de chenille a structures tubulaires, avec semelles a fixation par vis | |
IT1224250B (it) | Associzione del depiprazolo con la morfina | |
AU5198686A (en) | Praparat zur intramuskularen injektion von medikamenten vitaminen oder impfstoffen | |
ATE8966T1 (de) | Analgetische potenzierung. | |
IT8149852A0 (it) | Procedimento per la produzione dell'ormone adrenocorticotropico umano | |
ES2052467T1 (es) | Preparaciones farmaceuticas de alfa-dihidroergocriptina con actividad neuroprotectora. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 334465 Country of ref document: ES |